Global Tumor Ablation Market Size, Trend, Industry Analysis 2015-2024


Posted August 27, 2018 by kunalraut

Global Tumor Ablation Market is expected to reach USD 1.7 billion in 2015, and is expected to reach USD 2.9 billion by 2022, growing at a CAGR 8.2% during the forecast period 2016 to 2022.

 
Market Analysis:
Global Tumor Ablation Market is expected to reach USD 1.7 billion in 2015, and is expected to reach USD 2.9 billion by 2022, growing at a CAGR 8.2% during the forecast period 2016 to 2022.
The global tumour ablation market is segmented into 3 type’s ablation systems, image guidance products and accessories. The ablation systems dominates the market and is further segmented based on product type into microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled, catheter manipulation systems), high intensity focused ultrasound (HIFU), laser ablation and cryoablation. All ablation techniques are percutaneous except HIFU which is administered transcutaneously.
Request Free Sample Report of Global Tumor Ablation Market @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-tumour-ablation-market-2
Global Tumour Ablation Market – Competitive Landscape:
The Tumour Ablation Market’s major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some examples of recent strategies/developments are: On January, 2016 Medtronic acquired OsteoCool RF Ablation System from Baylis Medical and received its FDA approval, December, 2015 DFINE, Inc. launched Long SpineStar ablation system, January 2015, Medtronic acquired Covidien to strengthen its leadership in medical devices industry among others. The report includes market shares of tumor ablation market for global, Europe, North America, Asia Pacific and Rest of the World.
Browse complete TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-tumour-ablation-market-2
In 2015, RFA dominate the market owing to larger application area and a longer tenure, however the increasing acceptance of microwave ablation may cause a decline in RFA revenues by 2022. Microwave ablation is a more targeted approach where larger ablation zones are formed hence reducing heat caused damage to healthy tissues. Also the usage of laser ablation in brain cancer and prostate cancer is expected to drive the growth of this segment. HIFU is the brand new technology which has a advantage over RFA, such as decreased recurrence rates from 17% to 2% as per CDC data, a decreased ablation time and most importantly almost 50% cost effective than its counterpart.
By Type
• Tumour Ablation Systems
• (Radio Frequency Ablation,
• Microwave Ablation,
• HIFU,
• Laser Ablation,
• Cryoablation,
• Image Guidance Products,
• Accessories
By Cancer Type
• Liver,
• Lings,
• Kidney,
• Brain,
• Bone,
• Pancreas,
• Breast,
By End-User
• Hospitals,
• Oncology Clinics,
By Geography
• North America,
• South America,
• Europe,
• Asia-Pacific,
• Rest of the World
On the basis of cancer types treated using ablation devices the market is segmented into liver, lings, kidney, brain, bone, pancreas, breast and, other cancer types. In 2015, the liver cancer treatment is the most used application for ablation devices; however in the forecast period market potential for breast cancer is expected to be highest and is going to dominate the market by 2022.
Based on end-user the global tumour ablation market is segmented into hospitals, oncology clinics and others. In 2015, hospitals segment dominate the market with more than 65% market share. Oncology clinics is expected to grow at the highest CAGR of 10.3% in the forecast period, owing to development of less time consuming technologies like HIFU increasing in acceptance which will increase the outpatient surgeries which is already trending in global healthcare.
Do Inquiry About The Report Here: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-tumour-ablation-market-2

The Major Players in the Global Tumour Ablation Market
• Galil Medical, Inc.,
• Perseon Corporation,
• NeuWave Medical, Inc.,
• Koninklijke Philips N.V.,
• INTIO Inc.,
• Mermaid Medical A/S,
• SonaCare Medical,
• LLC,
• DFINE, Inc.,
• Misonix, Inc.,
• BVM Medical Limited,
• AngioDynamics, Inc.,
• COMSOL Inc.,
• Boston Scientific Corporation,
• EDAP TMS S.A.
• HealthTronics, Inc.
For more information about this report visit @ https://databridgemarketresearch.com/news/product-launch/global-tumour-ablation-market-2/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Data Bridge Market Research
Website https://databridgemarketresearch.com/news/product-launch/global-tumour-ablation-market-2/
Phone +1-888-387-2818
Business Address 402 Amanora Chambers, Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Country India
Categories Business
Tags global tumor ablation industry analysis , global tumor ablation market research report , global tumor ablation market , global tumor ablation research report , tumor ablation market
Last Updated August 27, 2018